ArticlePloS one2017

Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).

Xiao-Long Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.